| PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements | 09/16 16:30 | prnewswire.com |
| Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress | 09/10 07:56 | prnewswire.com |
| Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health | 09/03 07:51 | prnewswire.com |
| Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer | 08/20 08:16 | prnewswire.com |
| The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer | 08/13 08:16 | prnewswire.com |
| PAVmed Provides Business Update and Second Quarter 2024 Financial Results | 08/13 08:01 | prnewswire.com |
| Lucid Diagnostics Inc. (LUCD) Q2 2024 Earnings Call Transcript | 08/12 13:32 | seekingalpha.com |
| Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results | 08/12 08:07 | prnewswire.com |
| Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event | 08/08 08:31 | prnewswire.com |
| Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing | 08/06 08:15 | prnewswire.com |